Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Antenatal exposure to magnesium sulfate and the incidence of patent ductus arteriosus in extremely low birth weight infants

Journal of Perinatology volume 27, pages 154–157 (2007)Cite this article

Abstract

Objective:

Magnesium sulfate (MgSO4) is the most commonly used tocolytic agent in the US and is also employed as a prophylactic agent against seizures in pre-eclamptic women. MgSO4 crosses the placenta and its concentration in the newborn usually exceeds that of maternal levels. The purpose of this study was to explore the relationship between antenatal exposure to MgSO4 and the incidence of patent ductus arteriosus (PDA) in extremely low birth weight infants.

Study design:

A total of 954 neonates with birth weights between 500 and 1000 g, born at the University of Miami/Jackson Memorial Hospital between January 1995 and December 2004 and surviving for more than 3 days, were followed until death or discharge from the hospital. The incidence of PDA in infants exposed to MgSO4 was compared with those not exposed and comparisons were also made between infants exposed to different maternal doses of MgSO4.

Results:

The incidence of PDA was significantly higher in the group of infants exposed to MgSO4 compared with the unexposed control group (67 vs. 60%, P<0.018). When stratified by gestational age the differences were significant only in the group of infants with a gestational age of ⩾26 weeks (58 vs. 49%, P<0.039). Logistic regression analysis to adjust for co-variables indicated an increased risk of PDA with higher doses of MgSO4 (odds ratio 1.33 confidence interval (CI) 1.12 to 1.58, per 50 g of MgSO4).

Conclusion:

Antenatal exposure to MgSO4 is associated with a higher risk of PDA in extremely low birth weight infants and this effect is more significant and dose-related in more mature infants.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  1. Ramsey PS, Rouse DJ . Magnesium sulfate as a tocolytic agent. Semin Perinatol 2001; 25 (4): 236–247.

    Article  CAS  PubMed  Google Scholar 

  2. Handwerker SM, Altura BT, Jones KY, Altura BM . Maternal-fetal transfer of ionized serum magnesium during the stress of labor and delivery: a human study. J Am Coll Nutr 1995; 14: 376–381.

    Article  CAS  PubMed  Google Scholar 

  3. Pryde PG, Borg MJ, Mittendorf R, Elin RJ . Cord-blood ionized magnesium (iMg) exceeds maternal levels in both untreated and tocolytic magnesium sulfate treated preterm neonates. Am J Obstet Gynecol 1999; 184: S50.

    Google Scholar 

  4. Lemons JA, Vorh BR, Stevenson DK, Poole K, Das A, Bauer CR et al. In utero magnesium exposure: effects on ELBW infants at 18 months of age. Pediatr Res 2001; 49: 388A.

    Article  Google Scholar 

  5. Schendel DE, Berg CJ, Yeargin-Allsopp M, Boyle CA, Decoufle P . Prenatal magnesium sulfate exposure and the risk for cerebral palsy or mental retardation among very low-birth weight children aged 3–5 years. JAMA 1996; 276: 1805–1810.

    Article  CAS  PubMed  Google Scholar 

  6. Paneth N, Jetton J, Pinto-Martin J, Susser M . Magnesium sulfate in labor and risk of neonatal brain lesions and cerebral palsy in low birth weight infants. The neonatal brain hemorrhage study analysis group. Pediatrics 1997; 99: E1.

    Article  CAS  PubMed  Google Scholar 

  7. Canterino JC, Verma UL, Visintainer PF, Figueroa R, Klein SA, Tejani NA . Maternal magnesium sulfate and the development of neonatal periventricular leucomalacia and intraventricular hemorrhage. Obstet Gynecol 1999; 93: 396–402.

    CAS  PubMed  Google Scholar 

  8. Mittendorf R, Dambrosia J, Dammann O, Pryde PG, Lee KS, Ben-Ami TE et al. Association between maternal serum ionized magnesium levels at delivery and neonatal intraventricular hemorrhage. J Pediatr 2002; 140 (5): 540–546.

    Article  CAS  PubMed  Google Scholar 

  9. Mittendorf R, Roizen NJ, Pryde PG . The risks of extending the controversial use of tocolytic magnesium sulfate for the purpose of neuroprotection in preterm labor. J Perinatol 2004; 24 (7): 465–466.

    Article  PubMed  Google Scholar 

  10. Satake K, Lee JD, Shimizu H, Uzui H, Mitsuke Y, Yue H et al. Effects of magnesium on prostacyclin synthesis and intracellular free calcium concentration in vascular cells. Magnes Res 2004; 17 (1): 20–27.

    CAS  PubMed  Google Scholar 

  11. Takizawa T, Oda T, Arishima K, Yamamoto M, Masaoka T, Somiya H et al. A calcium channel blocker verapamil inhibits the spontaneous closure of the ductus arteriosus in newborn rats. J Toxicol Sci 1994; 19 (3): 171–174.

    Article  CAS  PubMed  Google Scholar 

  12. Kamitomo M, Sameshima H, Ikenoue T, Nishibatake M . Fetal cardiovascular function during prolonged magnesium sulfate tocolysis. J Perinat Med 2000; 28: 377–382.

    Article  CAS  PubMed  Google Scholar 

  13. Stigson L, Kjellmer I . Serum levels of magnesium at birth related to complications of immaturity. Acta Paediatr 1997; 86 (9): 991–994.

    Article  CAS  PubMed  Google Scholar 

  14. Tolsa JF, Gao Y, Raj JU . Developmental change in magnesium sulfate-induced relaxation of rabbit pulmonary arteries. J Appl Physiol 1999; 87 (5): 1589–1594.

    Article  CAS  PubMed  Google Scholar 

  15. Scudiero R, Khoshnood B, Pryde PG, Lee KS, Wall S, Mittendorf R . Perinatal death and tocolytic magnesium sulfate. Obstet Gynecol 2000; 96: 178–182.

    CAS  PubMed  Google Scholar 

  16. Crowther CA, Hiller JE, Doyle LW, Haslam RR . Effect of magnesium sulfate given for neuroprotection before preterm birth. JAMA 2003; 290 (20): 2669–2676.

    Article  CAS  PubMed  Google Scholar 

  17. Mittendorf R, Covert R, Boman J, Khoshnood B, Lee KS, Siegler M . Is tocolytic magnesium sulfate associated with increased total paediatric mortality? Lancet 1997; 350 (9090): 1517–1518.

    Article  CAS  PubMed  Google Scholar 

  18. Cox SM, Sherman ML, Leveno KJ . Randomized investigation of magnesium sulfate for prevention of preterm birth. Am J Obstet Gynecol 1990; 163: 767–772.

    Article  CAS  PubMed  Google Scholar 

  19. Crowther CA, Hiller JE, Doyle LW . Magnesium sulfate for preventing preterm birth in threatened preterm labour. Cochrane pregnancy and childbirth group. Cochrane Database of Systematic Reviews, 4 2006.

Download references

Acknowledgements

This study was supported by the University of Miami, Project Newborn, Presented in part at the Society for Materno-Fetal Medicine Annual Meeting, February 2006, Miami, Florida.

Author information

Authors and Affiliations

  1. Division of Neonatology, Department of Pediatrics, and the Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, University of Miami, Miller School of Medicine, Miami, FL, USA

    T del Moral, V H Gonzalez-Quintero, N Claure, S Vanbuskirk & E Bancalari

Authors
  1. T del Moral
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. V H Gonzalez-Quintero
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. N Claure
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. S Vanbuskirk
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. E Bancalari
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to T del Moral.

Rights and permissions

Reprints and permissions

About this article

Cite this article

del Moral, T., Gonzalez-Quintero, V., Claure, N. et al. Antenatal exposure to magnesium sulfate and the incidence of patent ductus arteriosus in extremely low birth weight infants. J Perinatol 27, 154–157 (2007). https://doi.org/10.1038/sj.jp.7211663

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.jp.7211663

Keywords

This article is cited by

Search

Advanced search

Quick links